Bracco Imaging S.p.A., a global leader in diagnostic imaging, announces that on 11 December 2025 the Committee for Medicinal ...

Discover the EMA's role in promoting safe medicine access in the EU. Learn about its responsibilities in drug evaluation, ...

EMA validates Type II Variation marketing authorization application of Datroway as first-line treatment for patients with metastatic TNBC who are not candidates for immunotherapy ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

The EU has reached a provisional deal requiring member states to screen foreign investments and changed its pharmaceutical legislation after over 20 years; and Hong Kong has warned investment banks ...

With the acceptance of international GMP standards and duty-free certainty for key APIs, India is poised to strengthen its ...

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a ...

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY ® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult ...

Anavex Life Sciences (AVXL) has formally asked the European Medicines Agency to re-examine its opinion made earlier in ...

Sanofi gains EMA Orphan Drug status for efdoralprin alfa, a phase II biologic for AATD-related emphysema with promising dosing data.

Core active pharmaceutical ingredients (APIs) such as penicillins, streptomyces, tetracyclines, and erythromycins also get ...

India’s pharma exports to Oman will get a boost as the Gulf nation will provide duty-free access to key finished medicines and vaccines, besides fast-tracking of regulatory approvals for domestic ...